Topic: David Juurlink
Patients taking the anti-diabetes drug Avandia may be at increased risk of cardiovascular ailments compared to those taking other drugs to treat diabetes, a US government study found Monday.The analysis by the US Food and Drug Administration was in line with ...
In elderly diabetics, pioglitazone may be associated with a significantly lower risk of heart failure and death than rosiglitazone, according to a study published online Aug. 18 in BMJ.. David N. Juurlink, M.D., of the Sunnybrook Health Sciences Centre in Toronto ...
The type 2 diabetes drug Avandia (rosiglitazone) increases the risk of heart failure and death more than another drug in the same class, Actos (pioglitazone), new Canadian research contends.. Avandia has been the subject of controversy since 2007, when it was linked ...
Heart attack patients who take both clopidogrel and a proton pump inhibitor other than pantoprazole have an increased risk of reinfarction and may lose the beneficial effects of clopidogrel, according to research published online Jan. 28 in CMAJ, the Canadian Medical Association ...
People taking the clot-preventing drug Plavix and an acid-reducing proton pump inhibitor medication after a heart attack have a dramatically higher risk of a second heart attack than those taking Plavix alone, a Canadian study finds.. A study of 16,000 people ...
Video Gallery
-
Clinical Epidemiology Rounds - Dr. David Juurlink ...
Title: Using Administrative Data to Study the Interactions between Drugs.2011-10-12 -
Dr. Irfan Dhalla - IHSPR-CIHR Rising Star ...
Dr. Irfan Dhalla IHSPR is pleased to announce the 2010 ...2011-01-17 -
Announcement for Patients Taking Common Cardiac ...
www.sunnybrook.ca Jan 29, 2009 - Patients who take the ...2009-05-13
